<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03768076</url>
  </required_header>
  <id_info>
    <org_study_id>POsT</org_study_id>
    <nct_id>NCT03768076</nct_id>
  </id_info>
  <brief_title>an Istitution Experience on Parosteal OsTeosarcoma</brief_title>
  <official_title>Parosteal OsTeosarcoma: a Single Istitution Experience</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Ortopedico Rizzoli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Ortopedico Rizzoli</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      single institution cases series review of histological and clinical data
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigators will review all the cases with a diagnosis of primary parosteal osteosarcoma
      treated at the Rizzoli Institute from 1900 up to 31 July 2018, retrospectively.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 30, 2018</start_date>
  <completion_date type="Anticipated">November 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>retrospective analysis of cases of Parosteal osteosarcoma</measure>
    <time_frame>at baseline (Day0)</time_frame>
    <description>Investigators will exam the presence of progression (dedifferentiation) areas and the relationship of these factors to individual outcome.</description>
  </primary_outcome>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Parosteal Osteosarcoma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        male and female with diagnosis of parosteal osteosarcoma treated at Rizzoli institute from
        01 Jan 1900 to 31 Jul 2018
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female patients treated at Rizzoli Institute from 01 Jan 1900 to 31 Jul 2018

          -  Diagnosis of parosteal osteosarcoma

          -  Written informed consent prior to any study-specific analysis and/or data collection

        Exclusion Criteria:

        â€¢ Patients with histological diagnosis different from parosteal osteosarcoma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Alberto Righi</last_name>
    <phone>+390516366</phone>
    <phone_ext>655</phone_ext>
    <email>alberto.righi@ior.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Istituto ortopedico Rizzoli</name>
      <address>
        <city>Bologna</city>
        <zip>40136</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alberto Righi, MD</last_name>
      <phone>051.63.66</phone>
      <phone_ext>665</phone_ext>
      <email>alberto.righi@ior.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Han I, Oh JH, Na YG, Moon KC, Kim HS. Clinical outcome of parosteal osteosarcoma. J Surg Oncol. 2008 Feb 1;97(2):146-9.</citation>
    <PMID>18050289</PMID>
  </results_reference>
  <results_reference>
    <citation>Bertoni F, Bacchini P, Staals EL, Davidovitz P. Dedifferentiated parosteal osteosarcoma: the experience of the Rizzoli Institute. Cancer. 2005 Jun 1;103(11):2373-82.</citation>
    <PMID>15852358</PMID>
  </results_reference>
  <results_reference>
    <citation>Okada K, Frassica FJ, Sim FH, Beabout JW, Bond JR, Unni KK. Parosteal osteosarcoma. A clinicopathological study. J Bone Joint Surg Am. 1994 Mar;76(3):366-78.</citation>
    <PMID>8126042</PMID>
  </results_reference>
  <results_reference>
    <citation>Laitinen M, Parry M, Albergo JI, Jeys L, Abudu A, Carter S, Sumathi V, Grimer R. The prognostic and therapeutic factors which influence the oncological outcome of parosteal osteosarcoma. Bone Joint J. 2015 Dec;97-B(12):1698-703. doi: 10.1302/0301-620X.97B12.35749.</citation>
    <PMID>26637687</PMID>
  </results_reference>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 22, 2018</study_first_submitted>
  <study_first_submitted_qc>December 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 7, 2018</study_first_posted>
  <last_update_submitted>December 12, 2018</last_update_submitted>
  <last_update_submitted_qc>December 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteosarcoma</mesh_term>
    <mesh_term>Osteosarcoma, Juxtacortical</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No Individual Patient Data sharing plan has been implemented</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 1, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/76/NCT03768076/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

